Freestone Capital Holdings, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 91 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Freestone Capital Holdings, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2020$119,895,000
-2.9%
1,633
-27.5%
0.01%
-12.5%
Q3 2020$123,467,000
+51131.1%
2,251
-42.7%
0.01%
+60.0%
Q1 2020$241,000
-80.9%
3,931
-72.5%
0.01%
-80.8%
Q4 2019$1,259,000
-16.0%
14,315
-28.0%
0.03%
-27.8%
Q3 2019$1,499,000
-30.1%
19,871
-20.9%
0.04%
-34.5%
Q2 2019$2,146,000
-84.7%
25,121
-80.6%
0.06%
-93.4%
Q1 2019$14,025,000
+71.5%
129,757
+34.3%
0.83%
+50.2%
Q4 2018$8,179,000
-40.9%
96,627
-31.3%
0.55%
+536.8%
Q3 2018$13,833,000
-17.5%
140,719
-2.9%
0.09%
-17.1%
Q2 2018$16,771,000
+1.9%
144,963
-13.1%
0.10%
-89.1%
Q1 2018$16,464,000
+8.2%
166,748
+14.7%
0.96%
-9.0%
Q4 2017$15,220,000
-8.4%
145,356
-1.4%
1.06%
-10.7%
Q3 2017$16,619,000
+3.9%
147,481
+3.3%
1.18%
-5.1%
Q2 2017$15,996,000
-3.6%
142,750
+0.3%
1.25%
-2.7%
Q1 2017$16,595,000
+85.7%
142,309
+67.6%
1.28%
+66.7%
Q4 2016$8,937,000
-9.1%
84,900
-4.6%
0.77%
-14.7%
Q3 2016$9,836,000
-43.8%
89,005
-25.9%
0.90%
-47.3%
Q2 2016$17,496,000
+8.2%
120,167
+6.4%
1.71%
+0.5%
Q1 2016$16,175,000
-11.9%
112,910
-5.0%
1.70%
-10.6%
Q4 2015$18,363,000
+1581.6%
118,819
+1455.6%
1.90%
+1497.5%
Q3 2015$1,092,0007,6380.12%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2020
NameSharesValueWeighting ↓
ISZO CAPITAL MANAGEMENT LP 582,409$90,011,00060.33%
GUARDIAN POINT CAPITAL, LP 70,000$10,819,00010.19%
Think Investments LP 186,373$28,804,0008.16%
Greywolf Capital Management LP 277,936$42,955,0007.45%
Valentine Capital Asset Management, Inc. 28,431$4,394,0004.91%
FORT, L.P. 63,675$9,841,0004.69%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 527,266$81,489,0003.63%
RPG Investment Advisory, LLC 60,910$9,413,0003.52%
Kerrisdale Advisers, LLC 81,996$12,672,0003.24%
Strategic Global Advisors, LLC 48,154$7,442,0003.17%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders